NIH-funded research R21 grant

How COVID-19 affects airway cell regeneration

Official title: COVID-19 imprints airway basal cells to impair epithelium regeneration

Funded at Massachusetts General Hospital · NIH-10914242 · Data updated 2026-11-12

This study is looking at how COVID-19 affects special cells in your airways that help heal them after infections, and it's for people who have had severe COVID-19 to help understand why these healing cells might not work as well afterward.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 25, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$208,750
NIH project number5R21AI173494-02
Project IDNIH-10914242 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced severe COVID-19 and are facing ongoing respiratory issues.

Less likely to help

Patients who have not been infected with COVID-19 or those with mild cases may not benefit from this research.

What this research studies

This research investigates the impact of COVID-19 on airway basal stem cells, which are crucial for repairing the airway epithelium after viral infections. By analyzing samples from patients with severe COVID-19, the study aims to understand how these cells become impaired in their ability to regenerate. The researchers will use advanced techniques to assess the function and characteristics of these cells, comparing them to those from patients with other respiratory issues. The goal is to uncover the mechanisms behind the damage caused by COVID-19 and identify potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance airway regeneration in COVID-19 patients, improving recovery and reducing long-term respiratory complications.

How similar studies have gone: Previous research has shown that understanding the cellular mechanisms of respiratory infections can lead to significant advancements in treatment, suggesting that this approach has potential for success.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Ai, Xingbin — Massachusetts General Hospital
  • Study coordinator: Ai, Xingbin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.